Literature DB >> 30769129

Paternal exposure to morphine during adolescence induces reward-resistant phenotype to morphine in male offspring.

Maryam Azadi1, Hossein Azizi2, Abbas Haghparast3.   

Abstract

The developing brain is extremely sensitive to drugs during adolescence. The devastating impacts of opioid abuse in this critical period not only do involve individuals but also are witnessed in the subsequent generations. Therefore, what is recognized as the population susceptible to the effects of opioid abuse could be much greater in number. In this study, we explored the transgenerational effects of morphine exposure in adolescent stage on morphine reward in male offspring through the patriline. Male Wistar rats underwent 10 days of incremental doses of morphine administration during adolescence; the broad spectrum of neurobehavioral alterations in rat adolescence is akin to that of human adolescence. Thereafter, following a 20-day wash-out period, adult males copulated with naïve females. The adult male offspring were examined for morphine (0, 1, 2 and 5 mg/kg)-induced conditioned place preference (CPP). Moreover, the spontaneous activity of ventral tegmental area (VTA) dopamine (DA) neurons was investigated utilizing extracellular single-unit recording technique. Our results demonstrated that paternal morphine exposure prior to conception leads to the development of a tolerance to the rewarding effects of morphine at the low dose of 1 mg/kg (rightward shift in dose-effect curve). Furthermore, morphine-sired rats elicited a decrease in spontaneous burst firing of VTA DA neurons (burst event frequency, bursting activity and burst duration) compared to saline-sired ones. Hence, our study has provided evidence that paternal morphine exposure during adolescence alters the rewarding effects of morphine in male offspring. This effect may be mediated in part by a decrease in phasic activation of VTA DA neurons.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescence; Conditioned place preference; Extracellular single-unit recording; Morphine; Transgenerational effects; Ventral tegmental area dopamine neurons

Mesh:

Substances:

Year:  2019        PMID: 30769129     DOI: 10.1016/j.brainresbull.2019.02.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  Generational Effects of Opioid Exposure.

Authors:  Katherine E Odegaard; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  Encyclopedia (Basel, 2021)       Date:  2021-01-18

2.  Exposure to drugs of abuse induce effects that persist across generations.

Authors:  Annalisa M Baratta; Richa S Rathod; Sonja L Plasil; Amit Seth; Gregg E Homanics
Journal:  Int Rev Neurobiol       Date:  2020-09-30       Impact factor: 3.230

3.  Sex-specific transgenerational effects of morphine exposure on reward and affective behaviors.

Authors:  Julia K Brynildsen; Victoria Sanchez; Nicole L Yohn; Marco D Carpenter; Julie A Blendy
Journal:  Behav Brain Res       Date:  2020-07-31       Impact factor: 3.332

4.  Preconception paternal morphine exposure leads to an impulsive phenotype in male rat progeny.

Authors:  Maryam Azadi; Parisa Moazen; Joost Wiskerke; Saeed Semnanian; Hossein Azizi
Journal:  Psychopharmacology (Berl)       Date:  2021-08-24       Impact factor: 4.530

Review 5.  The epigenetic legacy of illicit drugs: developmental exposures and late-life phenotypes.

Authors:  Nicole M Wanner; Mathia L Colwell; Christopher Faulk
Journal:  Environ Epigenet       Date:  2019-11-13

6.  Mapping the past, present and future research landscape of paternal effects.

Authors:  Joanna Rutkowska; Malgorzata Lagisz; Russell Bonduriansky; Shinichi Nakagawa
Journal:  BMC Biol       Date:  2020-11-27       Impact factor: 7.431

7.  Adolescent Substance Abuse, Transgenerational Consequences and Epigenetics.

Authors:  Hamed Salmanzadeh; S Mohammad Ahmadi-Soleimani; Maryam Azadi; Robert F Halliwell; Hossein Azizi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.